Participants 320 457 6
patients with supraventricular tachyarrhythmias (heart rate greater than 120 bpm) in a multicenter, double-blind, partial-crossover study
Participants 459 571 5
Seventy-one patients were randomized to receive either esmolol (n = 36) or placebo (n = 35) as initial treatment
